دورية أكاديمية
Sexual history of patients with human papillomavirus positive and negative oropharyngeal cancer: A systematic review and meta-analysis.
| العنوان: | Sexual history of patients with human papillomavirus positive and negative oropharyngeal cancer: A systematic review and meta-analysis. |
|---|---|
| المؤلفون: | Durrant FG; Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA., Gutierrez JA 3rd; Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA., Nguyen SA; Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA., Nathan CO; Department of Otolaryngology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA., Newman JG; Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA. |
| المصدر: | Head & neck [Head Neck] 2024 Mar 13. Date of Electronic Publication: 2024 Mar 13. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: New York, NY : John Wiley And Sons Original Publication: New York, NY : J. Wiley, c1989- |
| مستخلص: | Background: Increased sexual activity is associated with higher human papillomavirus (HPV) rates; however, there is a lack of analysis comparing the sexual history of patients with HPV positive and HPV negative oropharyngeal cancer (OPC). Methods: In this meta-analysis, PubMed, Scopus, and CINAHL were searched for articles that included patients with OPC and reported information regarding HPV status and either history of oral sex, number of sexual partners, or sexually transmitted infections (STI). Results: A total of 11 studies were included with 3296 patients with OPC. Patients with HPV positive OPC were more likely than patients with HPV negative OPC to report a history of oral sex (92%, 95% CI: 87.0-97.0 vs. 74.5%, 95% CI: 50.6-98.4, p < 0.0001), higher mean number of sexual partners (18.4 partners, 95% CI: 1.5-35.4 vs. 7.2 partners, 95% CI: 1.0-13.4, p < 0.0001), and more frequent history of STI (23.7%, 95% CI: 18.4-29.0 vs. 8.8%, 95% CI: 4.7-12.8, p = 0.0001). Conclusions: Compared to patients with HPV negative OPC, our analysis shows a larger proportion of patients with HPV positive OPC had participated in oral sex, had a higher number of sexual partners, and had a higher proportion of STI history. (© 2024 Wiley Periodicals LLC.) |
| References: | Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus-associated cancers-United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2018;67(33):918-924. doi:10.15585/mmwr.mm6733a2. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33(29):3235-3242. doi:10.1200/jco.2015.61.6995. Jemal A, Simard EP, Dorell C, et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105(3):175-201. doi:10.1093/jnci/djs491. Deeken JF, Newkirk K, Harter KW, et al. Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma. Head Neck. 2015;37(5):630-635. doi:10.1002/hed.23644. Vainshtein JM, Spector ME, Stenmark MH, et al. Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer. Oral Oncol. 2014;50(3):234-239. doi:10.1016/j.oraloncology.2013.12.003. Craig SG, Anderson LA, Schache AG, et al. Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach. Br J Cancer. 2019;120(8):827-833. doi:10.1038/s41416-019-0414-9. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944-1956. doi:10.1056/NEJMoa065497. Heck JE, Berthiller J, Vaccarella S, et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol. 2010;39(1):166-181. doi:10.1093/ije/dyp350. Day AT, Fakhry C, Tiro JA, Dahlstrom KR, Sturgis EM. Considerations in human papillomavirus-associated oropharyngeal cancer screening: a review. JAMA Otolaryngol Head Neck Surg. 2020;146(7):656-664. doi:10.1001/jamaoto.2019.4811. Caron SL, Moskey EG. Changes over time in teenage sexual relationships: comparing the high school class of 1950, 1975, and 2000. Adolescence Fall. 2002;37(147):515-526. Fakhry C, Blackford AL, Neuner G, et al. Association of oral human papillomavirus DNA persistence with cancer progression after primary treatment for oral cavity and oropharyngeal squamous cell carcinoma. JAMA Oncologia. 2019;5(7):985-992. doi:10.1001/jamaoncol.2019.0439. Smith EM, Pawlita M, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer. 2010;127(1):111-117. doi:10.1002/ijc.25015. Smith EM, Ritchie JM, Summersgill KF, et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer. 2004;108(5):766-772. doi:10.1002/ijc.11633. Crotty TJ, Keane E, Cousins G, Brennan S, Kinsella J, Moran T. Sexual behaviour and human papillomavirus-positive oral cavity and oropharyngeal cancer: an Irish perspective. Cureus. 2020;12(11):e11410. doi:10.7759/cureus.11410. Chen F, Yan L, Liu F, et al. Oral human papillomavirus infection, sexual behaviors and risk of oral squamous cell carcinoma in southeast of China: a case-control study. J Clin Virol. 2016;85:7-12. doi:10.1016/j.jcv.2016.10.011. Dahlstrom KR, Li G, Tortolero-Luna G, Wei Q, Sturgis EM. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck. 2011;33(6):847-855. doi:10.1002/hed.21550. Ferreira CC, Dufloth R, de Carvalho AC, et al. Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma. PloS One. 2021;16(6):e0253418. doi:10.1371/journal.pone.0253418. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097. Group OLoEW. The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine; 2011. Moola SMZ, Tufanaru C, Aromataris E, et al. Systematic reviews of etiology and risk. In: Aromataris EMZ, ed. JBI Manual for Evidence Synthesis. JBI; 2020. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. doi:10.1136/bmj.315.7109.629. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046-1055. doi:10.1016/s0895-4356(01)00377-8. Baumeister P, Reiter M, Welz C, Becker S, Betz C, Harréus U. Surgically treated oropharyngeal cancer: risk factors and tumor characteristics. J Cancer Res Clin Oncol. 2014;140(6):1011-1019. doi:10.1007/s00432-014-1631-5. Dahlstrom KR, Bell D, Hanby D, et al. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior. Oral Oncol. 2015;51(9):832-838. doi:10.1016/j.oraloncology.2015.06.005. Bahl A, Kumar P, Dar L, et al. Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian population. Head Neck. 2014;36(4):505-510. doi:10.1002/hed.23317. Shewale JB, Pickard RKL, Xiao W, Jiang B, Gillison ML. Independent association of marijuana use and poor oral hygiene with HPV-negative but not HPV-positive head and neck squamous cell carcinomas. Cancer. 2021;127(12):2099-2110. doi:10.1002/cncr.33440. Laprise C, Madathil SA, Schlecht NF, et al. Increased risk of oropharyngeal cancers mediated by oral human papillomavirus infection: results from a Canadian study. Head Neck. 2019;41(3):678-685. doi:10.1002/hed.25436. Anderson KS, Gerber JE, D'Souza G, et al. Biologic predictors of serologic responses to HPV in oropharyngeal cancer: the HOTSPOT study. Oral Oncol. 2015;51(8):751-758. doi:10.1016/j.oraloncology.2015.05.007. Meyer A, Alicea DA, Ferrandino RM, Miles BA. Behavioral analysis of HPV+ oropharyngeal cancer: do you know your patients? Am J Otolaryngol. 2019;40(3):377-381. doi:10.1016/j.amjoto.2019.02.006. Antonsson A, Knight L, Panizza BJ, Porceddu SV, Emmett S, Whiteman DC. HPV-16 viral load in oropharyngeal squamous cell carcinoma using digital PCR. Acta Otolaryngol. 2018;138(9):843-847. doi:10.1080/00016489.2018.1461239. Drake VE, Fakhry C, Windon MJ, et al. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer. Cancer. 2021;127(7):1029-1038. doi:10.1002/cncr.33346. Schroeder L, Pring M, Ingarfield K, et al. HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer. Oral Oncol. 2020;107:104721. doi:10.1016/j.oraloncology.2020.104721. Markowitz LE, Schiller JT. Human papillomavirus vaccines. J Infect Dis. 2021;224(12):S367-S378. doi:10.1093/infdis/jiaa621. Jit M, Brisson M, Portnoy A, Hutubessy R. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health. 2014;2(7):e406-14. doi:10.1016/s2214-109x(14)70237-2. El Hussein MT, Dhaliwal S. HPV vaccination for prevention of head and neck cancer among men. Nurse Pract. 2023;48(10):25-32. doi:10.1097/01.Npr.0000000000000099. Shingleton HM, Patrick RL, Johnston WW, Smith RA. The current status of the Papanicolaou smear. CA Cancer J Clin. 1995;45(5):305-320. Safaeian M, Solomon D, Castle PE. Cervical cancer prevention-cervical screening: science in evolution. Obstet Gynecol Clin North Am. 2007;34(4):739-760. Johannesson G, Geirsson G, Day N. The effect of mass screening in Iceland, 1965-74, on the incidence and mortality of cervical carcinoma. Int J Cancer. 1978;21(4):418-425. doi:10.1002/ijc.2910210404. Gillison ML, Alemany L, Snijders PJ, et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine. 2012;30:F34-F54. doi:10.1016/j.vaccine.2012.05.070. D'Souza G, Gross ND, Pai SI, et al. Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners. J Clin Oncol. 2014;32(23):2408-2415. doi:10.1200/jco.2014.55.1341. Nordfors C, Vlastos A, Du J, et al. Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer. Oral Oncol. 2014;50(5):491-497. doi:10.1016/j.oraloncology.2014.02.012. Fakhry C, Agrawal N, Califano J, et al. The use of ultrasound in the search for the primary site of unknown primary head and neck squamous cell cancers. Oral Oncol. 2014;50(7):640-645. doi:10.1016/j.oraloncology.2014.03.015. Blanco RG, Califano J, Messing B, et al. Transcervical ultrasonography is feasible to visualize and evaluate base of tongue cancers. PloS One. 2014;9(1):e87565. doi:10.1371/journal.pone.0087565. González-Ramírez I, Irigoyen-Camacho ME, Ramírez-Amador V, et al. Association between age and high-risk human papilloma virus in Mexican oral cancer patients. Oral Dis. 2013;19(8):796-804. doi:10.1111/odi.12071. Young D, Xiao CC, Murphy B, Moore M, Fakhry C, Day TA. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol. 2015;51(8):727-730. doi:10.1016/j.oraloncology.2015.03.015. Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB. The “new” head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol Head Neck Surg. 2014;151(3):375-380. doi:10.1177/0194599814538605. D'Souza G, Zhang HH, D'Souza WD, Meyer RR, Gillison ML. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol. 2010;46(2):100-104. doi:10.1016/j.oraloncology.2009.11.004. Sheth S, Farquhar DR, Lenze NR, et al. Decreased overall survival in black patients with HPV-associated oropharyngeal cancer. Am J Otolaryngol. 2021;42(1):102780. doi:10.1016/j.amjoto.2020.102780. Pike LRG, Royce TJ, Mahal AR, et al. Outcomes of HPV-associated squamous cell carcinoma of the head and neck: impact of race and socioeconomic status. J Natl Compr Canc Netw. 2020;18(2):177-184. doi:10.6004/jnccn.2019.7356. Fakhry C, Gillison ML, D'Souza G. Tobacco use and oral HPV-16 infection. Jama. 2014;312(14):1465-1467. doi:10.1001/jama.2014.13183. Kero K, Rautava J, Syrjänen K, Willberg J, Grenman S, Syrjänen S. Smoking increases oral HPV persistence among men: 7-year follow-up study. Eur J Clin Microbiol Infect Dis. 2014;33(1):123-133. doi:10.1007/s10096-013-1938-1. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100(6):407-420. doi:10.1093/jnci/djn025. |
| فهرسة مساهمة: | Keywords: head and neck cancer; human papillomavirus; oropharyngeal cancer; sexual behaviors; sexual history |
| تواريخ الأحداث: | Date Created: 20240313 Latest Revision: 20240313 |
| رمز التحديث: | 20240313 |
| DOI: | 10.1002/hed.27733 |
| PMID: | 38477218 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!